World Journal of
Pharmaceutical and Life Sciences

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Life Sciences
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
World Journal of Pharmaceutical and Life Sciences (WJPLS) has indexed with various reputed international bodies like : Google Scholar, Index Copernicus, Scintific journal impact factorScientific Journal Impact Factor (SJIF), Cosmos Impact Factor, International Society for Research Activity (ISRA) Journal Impact Factor (JIF), Directory of Research Journals Indexing, Scientific Indexing Services (SIS), UDLedge Science Citation Index, Global Impact Factor (In Process), International Impact Factor Services, Jour Informatics (Under Process), Indian citation Index (ICI), International Innovative Journal Impact Factor (IIJIF), Science Library Index, Dubai, United Arab Emirates, Scientific Journal Impact Factor (SJIF), Eurasian Scientific Journal Index (ESJI), IFSIJ Measure of Journal Quality, International Scientific Indexing, UAE (ISI), Web of Science Group (Under Process), Research Bible, Fuchu, Tokyo. JAPAN, Scholar Article Journal Index (SAJI), Scope Database, Academia, Doi-Digital Online Identifier, ISSN National Centre, Zenodo Indexing, International CODEN Service, USA, 

Abstract

A REVIEW ON CURRENT MEDICAL PARADIGMS PERTAINING TO THE MANAGEMENT OF FISTULA-IN-ANO

Dr. Preeti G. Verma*, Dr. Kamalakar V. Gajare

ABSTRACT

Cryptoglandular abscesses resulting from occluded and infected anal glands in the inter-sphincteric plane are the cause of anal fistulas. There are five grades and an incidence of 8.6 per 100,000. Anorectal fistulas can be brought on by foreign objects, radiation, infection, neoplasm, epithelialization, and distal obstruction. Obesity, diabetes, hyperlipidaemia, a history of surgery, salt consumption, smoking, and patients under 40 or with recurrent abscesses are risk factors. Imaging methods such as endo-anal ultrasound, CT pelvis, CT-fistulography, and pelvic MRI are crucial for diagnosis. The prognosis for anal fistulas varies; for sphincter-preserving procedures, the healing rate for simple fistulas is approximately 80%, while that of complex fistulas is approximately 60%. Up to 80–90% of setons have been successfully used; however, incomplete division, resection, or ligation can lead to failure. The gold standard for treating acute anal fistulas is fistulotomy, though there are other options. Reducing the number of procedures, customizing treatment for high-risk patients, educating patients about the risks of fecal incontinence, and obtaining preoperative imaging to more precisely classify fistulas are all important aspects of prevention.

[Full Text Article]   [Download Certificate]

WJPLS CITATION

  All Since 2020
 Citation  590  424
 h-index  12  10
 i10-index  17  14

INDEXING

NEWS & UPDATION

    A PHP Error was encountered

    Severity: Notice

    Message: Undefined variable: news

    Filename: views/right_panel.php

    Line Number: 79

    A PHP Error was encountered

    Severity: Warning

    Message: Invalid argument supplied for foreach()

    Filename: views/right_panel.php

    Line Number: 79

BEST ARTICLE AWARDS

World Journal of Pharmaceutical and life sciences is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here